Bisphosphonates may inhibit development of atherosclerosis formation through its bactericidal effect on nanobacteria.
Silay
Yavuz S
YS
Altundag
Kadri
K
Altundag
Ozden
O
Atik
Mustafa A
MA
Ozen
Mustafa
M
D001158:Arteries / Q000382:microbiology / Q000648:ultrastructure; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification / Q000648:ultrastructure; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy*; D002114:Calcinosis / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D004164:Diphosphonates / Q000494:pharmacology / Q000627:therapeutic use*; D006351:Heart Valves / Q000382:microbiology / Q000648:ultrastructure; D006801:Humans; D046529:Microscopy, Electron, Transmission
D004164:Diphosphonates